Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

Clinical trial NCT06203457 · COMPLETED

Trial details

NCT number: NCT06203457
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sjögren's Syndrome

Start date: 2023-11-29
Primary completion: 2025-02-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.